Who We Are

Hiranandani & Wang Capital is a strategic healthcare investment firm focused on backing high-potential companies across the global healthcare value chain. We go beyond traditional investment by taking an active role in our portfolio companies—contributing not just capital, but also deep strategic guidance, operational infrastructure, and scientific insight. Our team combines commercial execution experience with strong scientific acumen, enabling us to identify and scale ventures that are both innovative and impactful.

From early-stage R&D to full-scale commercialization, we work hand-in-hand with founders and institutions to accelerate growth, unlock intellectual property value, and navigate complex healthcare markets. We are especially focused on areas with transformative potential, including regenerative medicine, biotechnology, diagnostics, nuclear medicine, and AI-driven healthcare. Our commitment is to catalyze lasting impact—improving lives globally through intelligent capital, strategic integration, and long-term partnership.

Our Mission

To invest in transformative healthcare solutions that
improve lives globally
We believe capital should catalyze innovation, access,
and impact in medicine
Our mission is to invest in transformative, science-driven healthcare ventures that are commercially scalable, foster long-term partnerships built on trust, and are strategically positioned to bridge global markets through integrated, cross-border collaboration.

Strategic Global Presence

We operate across high-impact regions worldwide, positioning ourselves in both mature and emerging healthcare markets. This global positioning allows us to identify local innovation early, scale it internationally, and build regionally adapted strategies for long-term success.

Advanced R&D and Clinical Development

Our investment in global research and clinical development centers enables us to stay at the forefront of medical science. These hubs focus on next-generation therapies, clinical trials, and translational research—bridging the gap between lab discoveries and patient care.

Seamless Production and Distribution

Through a tightly integrated logistics and manufacturing network, we ensure timely, efficient, and quality-assured delivery of products. This infrastructure supports high-volume scale-up without compromising on regulatory or clinical standards.

Access to Top-Tier Talent and Markets

Our network gives us direct access to renowned medical professionals, researchers, and technical specialists. At the same time, we are embedded in fast-growing markets, enabling us to address both innovation and accessibility in one ecosystem.

Institutional Capital and Regulatory Alignment

We collaborate with global capital providers and regulators to ensure smooth market entry and cross-border scalability. Our regulatory alignment strategy simplifies product approvals and accelerates international commercialization.

Resilient, Decentralized Infrastructure

Our decentralized model reduces single-point dependencies and enhances our ability to adapt to geopolitical, regulatory, or supply chain disruptions. This resilience ensures business continuity and scalability across varying market conditions.

Global Reach, Local Impact

Investment Philosophy

We invest in companies addressing urgent and unmet medical needs. Whether it's improving access to regenerative therapies or advancing next-gen diagnostics, our capital is directed toward ventures that deliver tangible improvements in patient outcomes and public health.

Solving Real Medical Problems

We prioritize businesses with strong intellectual property, defensible technologies, and scalable models. Our goal is to support innovations that not only demonstrate clinical efficacy but also have clear pathways for growth, adoption, and commercial success across markets.

Preference for IP-Driven, Scalable Models

Beyond funding, we offer hands-on support to help companies structure for growth. This includes strategic planning, operational execution, IP licensing, regulatory navigation, and distribution strategy. Our partnership model is built to accelerate scale while ensuring long-term value creation.

Hands-On Capital: Strategy, Scale, and Structure

Our specialization

We focus exclusively on high-growth, high-impact healthcare verticals

Regenerative & Stem Cell Therapy

We invest in cutting-edge regenerative medicine ventures that aim to heal or replace damaged tissues and organs through cellular therapies. Our focus includes stem cell research, therapeutic applications, and clinical translation that offer new hope for chronic and degenerative conditions.

Biotechnology & Biologics

Our team backs biotech firms developing advanced biologics—therapies derived from living organisms that address complex diseases at the molecular level. This includes monoclonal antibodies, gene-editing platforms, and novel drug delivery technologies with the potential for global scalability.

Medical Devices & Diagnostics

We support companies that innovate in diagnostic and therapeutic technologies. From point-of-care devices to minimally invasive tools, these advancements enhance early detection, improve treatment precision, and drive better patient outcomes across care settings.

Nuclear Medicine & Theranostics

We strategically invest in this evolving field where diagnostics and treatment converge. Through radiopharmaceuticals and molecular imaging, our partners develop highly targeted methods to detect and treat diseases—particularly in oncology—at the cellular level.

Digital Health & AI-Driven Healthcare

We fund digital platforms and AI-based technologies that transform how care is delivered and decisions are made. From predictive analytics to virtual health, these innovations improve efficiency, accessibility, and personalization in healthcare systems worldwide.

Call To Action

We are seeking joint venture partners and acquisition targets to drive transformative healthcare together. Hiranandani & Wang welcomes collaboration with labs, clinics, and innovators aiming to scale impactful medical solutions through strategic alignment and shared growth.

Partner With Us